PT Siloam International Hospitals Tbk (SILO.JK)
IDR 2950.0
(-2.64%)
IDR 2950.0
(-2.64%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2692.46 Billion IDR | 44.77% |
| 2022 | 2014.11 Billion IDR | -0.25% |
| 2021 | 1988.28 Billion IDR | 108.99% |
| 2020 | 1208.64 Billion IDR | 185.79% |
| 2019 | 448.71 Billion IDR | -21.35% |
| 2018 | 705.41 Billion IDR | 10.43% |
| 2017 | 626.93 Billion IDR | 16.3% |
| 2016 | 581.34 Billion IDR | 24.56% |
| 2015 | 495.03 Billion IDR | 16.96% |
| 2014 | 413.34 Billion IDR | 61.43% |
| 2013 | 281.17 Billion IDR | 3.3% |
| 2012 | 117.52 Billion IDR | 32.25% |
| 2011 | 96 Billion IDR | -12.6% |
| 2010 | 109.85 Billion IDR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 668.99 Billion IDR | -3.55% |
| 2024 Q2 | 696.61 Billion IDR | 70.92% |
| 2024 Q1 | 714.26 Billion IDR | -44.14% |
| 2023 Q3 | 704.33 Billion IDR | 22.82% |
| 2023 Q2 | 573.45 Billion IDR | 1.12% |
| 2023 Q1 | 567.13 Billion IDR | 3.1% |
| 2023 FY | - IDR | 44.77% |
| 2023 Q4 | 694.31 Billion IDR | -1.42% |
| 2022 FY | - IDR | -0.25% |
| 2022 Q4 | 550.1 Billion IDR | 2.45% |
| 2022 Q3 | 536.95 Billion IDR | 46.9% |
| 2022 Q2 | 365.52 Billion IDR | -0.82% |
| 2022 Q1 | 368.56 Billion IDR | -3.28% |
| 2021 Q4 | 381.07 Billion IDR | -27.47% |
| 2021 Q2 | 427.91 Billion IDR | -12.93% |
| 2021 Q3 | 525.39 Billion IDR | 22.78% |
| 2021 FY | - IDR | 108.99% |
| 2021 Q1 | 491.47 Billion IDR | 38.38% |
| 2020 FY | - IDR | 185.79% |
| 2020 Q2 | 10.28 Billion IDR | -95.53% |
| 2020 Q1 | 230.08 Billion IDR | 197.09% |
| 2020 Q4 | 355.15 Billion IDR | 31.23% |
| 2020 Q3 | 270.64 Billion IDR | 2531.95% |
| 2019 FY | - IDR | -21.35% |
| 2019 Q3 | 168.27 Billion IDR | 65.47% |
| 2019 Q2 | 101.69 Billion IDR | -13.91% |
| 2019 Q4 | -236.97 Billion IDR | -240.83% |
| 2019 Q1 | 118.11 Billion IDR | -3.71% |
| 2018 Q3 | 129.88 Billion IDR | 134.21% |
| 2018 Q4 | 122.67 Billion IDR | -5.55% |
| 2018 FY | - IDR | 10.43% |
| 2018 Q1 | 88.15 Billion IDR | -17.23% |
| 2018 Q2 | 55.45 Billion IDR | -37.09% |
| 2017 FY | - IDR | 16.3% |
| 2017 Q3 | 105.89 Billion IDR | 142.05% |
| 2017 Q1 | 102.58 Billion IDR | 91.28% |
| 2017 Q4 | 106.5 Billion IDR | 0.58% |
| 2017 Q2 | 43.74 Billion IDR | -57.36% |
| 2016 Q3 | 68.32 Billion IDR | -26.07% |
| 2016 FY | - IDR | 24.56% |
| 2016 Q2 | 92.41 Billion IDR | -1.77% |
| 2016 Q1 | 94.08 Billion IDR | 130.15% |
| 2016 Q4 | 53.63 Billion IDR | -21.5% |
| 2015 Q1 | 85.83 Billion IDR | 64.82% |
| 2015 Q2 | 77.99 Billion IDR | -9.13% |
| 2015 FY | - IDR | 16.96% |
| 2015 Q4 | 40.87 Billion IDR | -4.8% |
| 2015 Q3 | 42.94 Billion IDR | -44.94% |
| 2014 Q3 | 45.77 Billion IDR | -17.75% |
| 2014 Q2 | 55.65 Billion IDR | -4.41% |
| 2014 Q1 | 58.22 Billion IDR | -1.59% |
| 2014 FY | - IDR | 61.43% |
| 2014 Q4 | 52.07 Billion IDR | 13.76% |
| 2013 Q4 | 59.16 Billion IDR | 204.12% |
| 2013 Q1 | 46.5 Billion IDR | 114.0% |
| 2013 FY | - IDR | 3.3% |
| 2013 Q2 | 6.04 Billion IDR | -87.0% |
| 2013 Q3 | 19.45 Billion IDR | 221.86% |
| 2012 Q4 | 21.73 Billion IDR | 0.0% |
| 2012 FY | - IDR | 32.25% |
| 2011 FY | - IDR | -12.6% |
| 2010 FY | - IDR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| PT Bundamedik Tbk | 223.9 Billion IDR | -1102.489% |
| PT Metro Healthcare Indonesia Tbk | -7.68 Billion IDR | 35157.171% |
| PT Medikaloka Hermina Tbk | 1584.42 Billion IDR | -69.933% |
| PT Mitra Keluarga Karyasehat Tbk | 1555.38 Billion IDR | -73.106% |
| PT Murni Sadar Tbk | 155.6 Billion IDR | -1630.296% |
| PT Famon Awal Bros Sedaya Tbk | 443.01 Billion IDR | -507.766% |
| PT Royal Prima Tbk | 52.4 Billion IDR | -5037.515% |
| PT Kedoya Adyaraya Tbk | 61.12 Billion IDR | -4305.075% |
| PT Sarana Meditama Metropolitan Tbk | 323.18 Billion IDR | -733.101% |
| PT Sejahteraraya Anugrahjaya Tbk | 437.22 Billion IDR | -515.803% |